Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07014371

Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA)

Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA): A Multicenter, Randomized, Open-Label, Non-Inferiority Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
114 (estimated)
Sponsor
Phramongkutklao College of Medicine and Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare the effectiveness and tolerability of two different oral iron regimens in adults with iron deficiency anemia (IDA). The main questions it aims to answer are: Is alternate-day oral iron supplementation as effective as once-daily dosing in improving hemoglobin levels? What are the side effects associated with each dosing regimen? Researchers will compare once-daily vs. alternate-day oral ferrous fumarate to evaluate whether alternate-day dosing is non-inferior in terms of hematologic response, with fewer adverse effects. Participants will: Be randomly assigned to take ferrous fumarate 200 mg once daily or 400 mg on alternate days for 8 weeks Undergo blood tests and clinical assessments at baseline, Week 4, and Week 8 Report any side effects and bring remaining pills to evaluate medication adherence This is a multicenter, randomized, open-label, non-inferiority trial conducted in adults aged 20 years or older with IDA.

Conditions

Interventions

TypeNameDescription
DRUGFerrous Fumarate Oral TabletFerrous fumarate oral tablet 200 mg is an iron supplement used for the treatment of iron deficiency anemia (IDA). In this study, it is administered as either one tablet daily (OD group) or two tablets on alternate days (AD group), with a treatment duration of 8 weeks. The goal is to compare the efficacy and tolerability of alternate-day dosing versus standard once-daily dosing.

Timeline

Start date
2025-06-09
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2025-06-11
Last updated
2026-01-07

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT07014371. Inclusion in this directory is not an endorsement.